APA

Giannoudis A., Wang L., Jorgensen A. L., Xinarianos G., Davies A., Pushpakom S., Liloglou T., Zhang J., Austin G., Holyoake T. L., Foroni L., Kottaridis P. D., Müller M. C., Pirmohamed M. & Clark R. E. (20130321). The hOCT1 SNPs M420del and M408V alter imatinib uptake and M420del modifies clinical outcome in imatinib-treated chronic myeloid leukemia. : Blood.

Chicago

Giannoudis Athina, Wang Lihui, Jorgensen Andrea L, Xinarianos George, Davies Andrea, Pushpakom Sudeep, Liloglou Triantafilos, Zhang Jieying-Eunice, Austin Gemma, Holyoake Tessa L, Foroni Letizia, Kottaridis Panagiotis D, Müller Martin C, Pirmohamed Munir and Clark Richard E. 20130321. The hOCT1 SNPs M420del and M408V alter imatinib uptake and M420del modifies clinical outcome in imatinib-treated chronic myeloid leukemia. : Blood.

Harvard

Giannoudis A., Wang L., Jorgensen A. L., Xinarianos G., Davies A., Pushpakom S., Liloglou T., Zhang J., Austin G., Holyoake T. L., Foroni L., Kottaridis P. D., Müller M. C., Pirmohamed M. and Clark R. E. (20130321). The hOCT1 SNPs M420del and M408V alter imatinib uptake and M420del modifies clinical outcome in imatinib-treated chronic myeloid leukemia. : Blood.

MLA

Giannoudis Athina, Wang Lihui, Jorgensen Andrea L, Xinarianos George, Davies Andrea, Pushpakom Sudeep, Liloglou Triantafilos, Zhang Jieying-Eunice, Austin Gemma, Holyoake Tessa L, Foroni Letizia, Kottaridis Panagiotis D, Müller Martin C, Pirmohamed Munir and Clark Richard E. The hOCT1 SNPs M420del and M408V alter imatinib uptake and M420del modifies clinical outcome in imatinib-treated chronic myeloid leukemia. : Blood. 20130321.